Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...

EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) ...

Explore how nutrition plays a crucial role in cancer prevention, treatment, and recovery, emphasizing the power of a balanced ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the ...

The extreme weight loss seen in many late-stage cancer patients, known as cachexia, is far more than a cosmetic side effect.

The research suggests that fixing blood vessels in cancer patients and cancer survivors could be a new way to prevent or reverse cachexia. Tumors can destroy the blood vessels of muscles even when the ...

Cancer takes a devastating toll on the body—but the psychological burden can be just as profound. Many patients, even those with a long history of resilience and optimism, experience notable emotional ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

Nat Clin Pract Oncol. 2005;2(3):158-165. F Rossi-Fanelli received a research grant from the Ross Products Division of Abbott Laboratories, Columbus, Ohio, USA. Abbott Laboratories produces a caloric ...